4
Changes in Ownership
Viridian Therapeutics, Inc.DE Filed Acc 0001193125-26-092071
Chief Financial Officer gave up 2,091 shares (to pay taxes)
- Chief Financial Officer acquired 6,267 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Harmon Seth · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-03 | Exercise or conversion : show line 1 in the form | +6,267 | 9,881 | D | ||
| 2026-03-03 | Shares withheld for taxes : show line 2 in the form | −2,091 | $29.32 | $61,308 | 7,790 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-02 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +102,850 | 102,850 | D |
| 2026-03-02 | Grant or award : show line 4 in the form Restricted Stock Units | +20,550 | 20,550 | D |
| 2026-03-03 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −6,267 | 18,801 | D |
Loading xslF345X05/ownership.xml…